ANTEGRIN.COM
Antegrin | Novel Compounds for the Treatment of Fibrotic DiseasesAntegrin Therapeutics is a pharmaceutical company dedicated to the development of novel therapies for fibrotic diseases.
http://www.antegrin.com/
Antegrin Therapeutics is a pharmaceutical company dedicated to the development of novel therapies for fibrotic diseases.
http://www.antegrin.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
5.2 seconds
Domains By Proxy, LLC
Registration Private
Domain●●●●●●xy.com
14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309
Sco●●●ale , Arizona, 85260
United States
View this contact
Domains By Proxy, LLC
Registration Private
Domain●●●●●●xy.com
14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309
Sco●●●ale , Arizona, 85260
United States
View this contact
Domains By Proxy, LLC
Registration Private
Domain●●●●●●xy.com
14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309
Sco●●●ale , Arizona, 85260
United States
View this contact
BUY YOUR DOMAIN
13
YEARS
8
MONTHS
12
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
9
SSL
EXTERNAL LINKS
2
SITE IP
192.250.225.9
LOAD TIME
5.161 sec
SCORE
6.2
Antegrin | Novel Compounds for the Treatment of Fibrotic Diseases | antegrin.com Reviews
https://antegrin.com
Antegrin Therapeutics is a pharmaceutical company dedicated to the development of novel therapies for fibrotic diseases.
antegrin.com
Publication | Antegrin
http://www.antegrin.com/category/publication
Novel Compounds for the Treatment of Fibrotic Diseases. Ulmasov B, et al. 2016. April 14, 2016. Henderson NC, et al. 2013. November 12, 2013. Antegrin Spotlighted in BioWorld. Daily Biopharmaceutical News Source Profiles Antegrin’s Program Antegrin’s innovative approach continues to attract positive attention in the industry. On April 13, 2016, the company’s latest updates were highlighted in BioWorld Today. Read the whole article here. Paper Further Validates Company’s Innovative Approach ST. LOUIS&...
Team | Antegrin
http://www.antegrin.com/team
Novel Compounds for the Treatment of Fibrotic Diseases. Chief Executive Officer: George H. Capps, M.S., M.B.A. Executive Chairman of the Board: Rajesh Devraj, Ph.D. Board Member: Michael Yeadon, Ph.D. Board Member: Robert Karr, M.D. Board Member: Thomas P. Cirrito, Ph.D. Board Member: Charles W. Bolten. Co-Founder and Board Member: David Griggs, Ph.D. Integrin functional assays as well as diverse in vivo. Co-Founder and Scientific Advisor: Peter Ruminski, M.S. Antegrin Spotlighted in BioWorld. Paper Furt...
Antegrin Announces Publication in Nature Medicine of Preclinical Data in Fibrosis Models | Antegrin
http://www.antegrin.com/2013/11/12/antegrin-announces-publication-in-nature-medicine-of-preclinical-data-in-fibrosis-models
Novel Compounds for the Treatment of Fibrotic Diseases. Antegrin Announces Publication in Nature Medicine of Preclinical Data in Fibrosis Models. November 12, 2013. Paper Describes and Validates Rationale for Company’s Innovative Approach. ST LOUIS–(BUSINESS WIRE)–Antegrin Therapeutics, a drug discovery and development company focused on novel treatments for fibrotic diseases, announced today the publication of key preclinical data in the current online issue of. Read the whole press release here. Paper ...
Henderson NC, et al. 2013 | Antegrin
http://www.antegrin.com/2013/11/12/henderson-nc-et-al-2013
Novel Compounds for the Treatment of Fibrotic Diseases. Henderson NC, et al. 2013. November 12, 2013. Henderson NC, et al. Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med. 2013 [Epub ahead of print]. Antegrin Spotlighted in BioWorld. Antegrin Announces Publication of Preclinical Data in Pancreatic Fibrosis. Antegrin Therapeutics, Inc., is a drug discovery and development company focused on the development of novel therapies for fibrotic ...
George Capps | Antegrin
http://www.antegrin.com/author/capps
Novel Compounds for the Treatment of Fibrotic Diseases. Ulmasov B, et al. 2016. April 14, 2016. Antegrin Spotlighted in BioWorld. April 13, 2016. Daily Biopharmaceutical News Source Profiles Antegrin’s Program Antegrin’s innovative approach continues to attract positive attention in the industry. On April 13, 2016, the company’s latest updates were highlighted in BioWorld Today. Read the whole article here. Antegrin Announces Publication of Preclinical Data in Pancreatic Fibrosis. April 12, 2016. Nationa...
TOTAL PAGES IN THIS WEBSITE
9
Portfolio
http://www.missouritechnology.com/portfolio
Seed Capital Co-Investment Program. Venture Capital Co-Investment Program. High-Tech Industrial Expansion Program. Research Alliance of Missouri. Missouri Life Sciences Research Board. Life Sciences Research Trust Fund. MLSRB Frequently Asked Questions. University of Missouri Technology Park at Fort Leonard Wood. Missouri Plant Science Center. Conflicts of Interest Policy. Is a medical device company located in St. Louis, Missouri developing a first-in-class line of implantable electrospun neurosurgi...
Portfolio Companies
http://www.iselectfund.com/iselect/portfolio-companies
News & Insights. Neuros Medical, Inc. A Cleveland, Ohio based neuromodulation company, is focused on developing proprietary therapies for unmet needs to patients worldwide. The company’s patented platform technology, Altius Electrical Nerve Block, is focused on elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post-surgical pain, and chronic migraine. Develops novel, small-molecule integrin inhibitors for the treatment of fibrotic diseases. Make Flip T...
TOTAL LINKS TO THIS WEBSITE
2
Domain Registered at Safenames
Domain Registration in over 800 different extensions. Enterprise Domain Management since 1999. Online Brand Monitoring and Enforcement. Domain Consultancy and Strategy. Domain Disputes and Recovery. Web Hosting and Data Center Solutions. Please visit www.safenames.net. Europe, Middle East and Africa: 44 1908 200022. USA, Canada and South America: 1 703 574 5313. Australia and Asia-Pacific: 61 755 245 575.
Domain Registered at Safenames
Domain Registration in over 800 different extensions. Enterprise Domain Management since 1999. Online Brand Monitoring and Enforcement. Domain Consultancy and Strategy. Domain Disputes and Recovery. Web Hosting and Data Center Solutions. Please visit www.safenames.net. Europe, Middle East and Africa: 44 1908 200022. USA, Canada and South America: 1 703 574 5313. Australia and Asia-Pacific: 61 755 245 575.
Domain Registered at Safenames
Domain Registration in over 800 different extensions. Enterprise Domain Management since 1999. Online Brand Monitoring and Enforcement. Domain Consultancy and Strategy. Domain Disputes and Recovery. Web Hosting and Data Center Solutions. Please visit www.safenames.net. Europe, Middle East and Africa: 44 1908 200022. USA, Canada and South America: 1 703 574 5313. Australia and Asia-Pacific: 61 755 245 575.
Domain Registered at Safenames
Domain Registration in over 800 different extensions. Enterprise Domain Management since 1999. Online Brand Monitoring and Enforcement. Domain Consultancy and Strategy. Domain Disputes and Recovery. Web Hosting and Data Center Solutions. Please visit www.safenames.net. Europe, Middle East and Africa: 44 1908 200022. USA, Canada and South America: 1 703 574 5313. Australia and Asia-Pacific: 61 755 245 575.
Domain Registered at Safenames
Domain Registration in over 800 different extensions. Enterprise Domain Management since 1999. Online Brand Monitoring and Enforcement. Domain Consultancy and Strategy. Domain Disputes and Recovery. Web Hosting and Data Center Solutions. Please visit www.safenames.net. Europe, Middle East and Africa: 44 1908 200022. USA, Canada and South America: 1 703 574 5313. Australia and Asia-Pacific: 61 755 245 575.
Antegrin | Novel Compounds for the Treatment of Fibrotic Diseases
Novel Compounds for the Treatment of Fibrotic Diseases. Attacking the molecular and cellular drivers of fibrosis at their source. Designing innovative small-molecule inhibitors of fibrotic scarring. Developing novel drugs for pulmonary fibrosis and other debilitating fibrotic conditions. Pursuing therapeutic options for millions of patients suffering from life-threatening diseases. Antegrin Announces Publication in Nature Medicine of Preclinical Data in Fibrosis Models. November 12, 2013. Antegrin Therap...
Antegrity Enterprises, LLC
Antegrity Enterprises, LLC. Sign Up to Be an Investigator. Sign Up to Be a Marketing Panelist. Animal Health Research with Integrity".
特级酒精|药用酒精|脱醛酒精无水|药用乙醇|无水乙醇|无水乙醇试剂|安特谷朊粉|安特淀粉|安特变性淀粉|曹溪系列|曲酒系列|洋酒-伏特加酒--安徽安特食品股份有限公司
ANTE GRUP - Güvenilir çözüm ortağınız…
Özellikle KOBİ seviyesinde faaliyet gösteren firmaların CRM kullanmalarının satışlarına doğrudan yansıyacağını ve müşterilerimizin satışlarına yansıyacak artışların bizim en büyük referansımız olacağına inanıyoruz. ERP sistemlerinin günümüzde bu kadar popüler olmasının sebeplerinin başında, uzun dönem planlamalarda kullanılacak analiz ve raporlara ulaşmayı kolaylaştırarak, firmalara rekabet gücünü arttırmasında önemli bir artı kazandırmasıdır.
sachiyo49 sozai page | sachiyo49 sozai page
On: 10月 13, 2014. On: 10月 13, 2014. On: 10月 13, 2014. On: 10月 13, 2014. On: 10月 13, 2014. On: 10月 13, 2014. On: 10月 13, 2014. Sachiyo49 sozai page をフォロー. WordPress.com を使って Web サイトを作成する. Add your thoughts here. (optional).
